HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen J Nicholls Selected Research

Messenger RNA (mRNA)

3/2024TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated Angiogenesis.
1/2021Elevated HDL-bound miR-181c-5p level is associated with diabetic vascular complications in Australian Aboriginal people.
1/2021Circadian disruption by short light exposure and a high energy diet impairs glucose tolerance and increases cardiac fibrosis in Psammomys obesus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen J Nicholls Research Topics

Disease

107Coronary Artery Disease (Coronary Atherosclerosis)
06/2024 - 10/2004
105Atherosclerotic Plaque (Atheroma)
06/2024 - 08/2005
85Cardiovascular Diseases (Cardiovascular Disease)
06/2024 - 01/2005
75Atherosclerosis
02/2024 - 10/2004
54Myocardial Infarction
04/2024 - 07/2007
36Inflammation (Inflammations)
03/2024 - 06/2005
36Acute Coronary Syndrome
11/2023 - 01/2008
32Stroke (Strokes)
04/2024 - 09/2007
29Type 2 Diabetes Mellitus (MODY)
06/2024 - 09/2007
28Coronary Disease (Coronary Heart Disease)
11/2023 - 04/2006
21Disease Progression
02/2021 - 04/2006
18Heart Failure
06/2023 - 09/2007
17Dyslipidemias (Dyslipidemia)
07/2023 - 03/2007
15Hypertension (High Blood Pressure)
11/2023 - 06/2006
15Unstable Angina
10/2022 - 11/2012
14Thrombosis (Thrombus)
03/2024 - 08/2006
14Vascular Diseases (Vascular Disease)
10/2022 - 09/2007
10ST Elevation Myocardial Infarction
01/2022 - 08/2013
10Diabetes Mellitus
01/2021 - 01/2010
9Hypertriglyceridemia
12/2020 - 05/2010
8Pathologic Constriction (Stenosis)
02/2024 - 11/2006
8AIDS-Related Complex (ARC)
01/2023 - 08/2014
7Ischemia
12/2022 - 03/2014
7Hemorrhage
10/2022 - 01/2018
6Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2024 - 04/2008
5Hypoxia (Hypoxemia)
03/2024 - 01/2018
5Obesity
02/2024 - 06/2006
5Hypercholesterolemia
01/2024 - 03/2007
5Neoplasms (Cancer)
12/2023 - 01/2019
5Hyperlipidemias (Hyperlipidemia)
11/2023 - 11/2011
4Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
05/2024 - 01/2017
4Body Weight (Weight, Body)
02/2024 - 04/2008
4Cholelithiasis
01/2024 - 04/2023
4Gout
01/2024 - 04/2023
4Genetic Risk Score
10/2023 - 10/2019
4Chronic Renal Insufficiency
01/2023 - 05/2013
4Rupture
01/2022 - 08/2013
3Aortic Valve Stenosis (Aortic Stenosis)
04/2024 - 01/2023
3Ischemic Stroke
02/2024 - 11/2012
3Heart Diseases (Heart Disease)
01/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

79Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2024 - 11/2005
67LipidsIBA
05/2024 - 12/2005
53LDL CholesterolIBA
05/2024 - 02/2007
40oxidized low density lipoproteinIBA
05/2024 - 01/2006
39HDL CholesterolIBA
07/2023 - 02/2007
27CholesterolIBA
04/2024 - 06/2005
26Lipoproteins (Lipoprotein)IBA
05/2024 - 02/2007
26HDL LipoproteinsIBA
04/2024 - 08/2005
26Atorvastatin (Lipitor)FDA Link
01/2022 - 11/2005
25Triglycerides (Triacylglycerol)IBA
04/2024 - 03/2007
24omega-Chloroacetophenone (Mace)IBA
02/2024 - 05/2010
24C-Reactive ProteinIBA
01/2024 - 06/2006
22Rosuvastatin Calcium (Crestor)FDA Link
11/2019 - 04/2006
17Cholesterol Ester Transfer ProteinsIBA
07/2023 - 06/2005
14Lipoprotein(a)IBA
04/2024 - 08/2017
14CalciumIBA
10/2023 - 01/2007
14evacetrapibIBA
10/2022 - 11/2011
13Apolipoprotein A-I (Apolipoprotein A1)IBA
04/2024 - 02/2007
13Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2008
12Proteins (Proteins, Gene)FDA Link
04/2024 - 10/2007
12evolocumabIBA
01/2023 - 06/2016
12apabetaloneIBA
09/2022 - 03/2011
12LDL Lipoproteins (beta Lipoproteins)IBA
01/2022 - 05/2007
9Glucose (Dextrose)FDA LinkGeneric
10/2023 - 04/2012
9ApolipoproteinsIBA
07/2023 - 02/2007
9Peroxidase (Myeloperoxidase)IBA
02/2014 - 10/2004
88- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA
01/2024 - 01/2021
7PCSK9 InhibitorsIBA
11/2023 - 06/2016
5CreatinineIBA
01/2024 - 03/2007
5Immune Checkpoint InhibitorsIBA
12/2023 - 12/2022
5Proprotein Convertase 9IBA
11/2023 - 12/2016
5Ezetimibe (Zetia)FDA Link
01/2023 - 09/2013
5empagliflozinIBA
12/2022 - 10/2020
5Insulin (Novolin)FDA Link
02/2022 - 04/2008
5Phenobarbital (Luminal)FDA Link
01/2020 - 03/2006
5aleglitazarIBA
01/2020 - 09/2013
4EnzymesIBA
11/2023 - 07/2006
4TicagrelorIBA
01/2022 - 01/2018
4Clopidogrel (Plavix)FDA Link
01/2022 - 01/2018
4Apolipoproteins B (ApoB)IBA
12/2020 - 01/2016
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2020 - 09/2013
4Albuterol (Salbutamol)FDA LinkGeneric
01/2018 - 11/2014
4Pioglitazone (Actos)FDA Link
07/2015 - 09/2007
4Oxidants (Oxidizing Agents)IBA
03/2010 - 10/2004
3CSL112IBA
04/2024 - 01/2021
3Messenger RNA (mRNA)IBA
03/2024 - 01/2021
3tirzepatideIBA
02/2024 - 01/2022
3Apolipoproteins E (ApoE)IBA
01/2023 - 01/2021
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2022 - 11/2018
3torcetrapibIBA
01/2022 - 03/2007

Therapy/Procedure

116Therapeutics
05/2024 - 06/2005
8Secondary Prevention
12/2023 - 08/2019
8Percutaneous Coronary Intervention
10/2022 - 07/2012
7Stents
03/2024 - 01/2018
6Glycemic Control
02/2024 - 09/2007
6Transcatheter Aortic Valve Replacement
01/2023 - 08/2016
4Drug-Eluting Stents
10/2022 - 07/2012
4Thrombolytic Therapy
01/2022 - 01/2018
3Cardiac Rehabilitation
02/2022 - 04/2019
3Drug Therapy (Chemotherapy)
01/2021 - 06/2014